Cencora Operating Income 2010-2024 | COR
Cencora annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Cencora operating income for the quarter ending December 31, 2024 was $0.706B, a 14.17% decline year-over-year.
- Cencora operating income for the twelve months ending December 31, 2024 was $2.059B, a 18.64% decline year-over-year.
- Cencora annual operating income for 2024 was $2.175B, a 7.07% decline from 2023.
- Cencora annual operating income for 2023 was $2.341B, a 1.08% decline from 2022.
- Cencora annual operating income for 2022 was $2.366B, a 0.52% increase from 2021.
| Cencora Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $2,175 |
| 2023 | $2,341 |
| 2022 | $2,366 |
| 2021 | $2,354 |
| 2020 | $-5,135 |
| 2019 | $1,112 |
| 2018 | $1,444 |
| 2017 | $1,060 |
| 2016 | $1,526 |
| 2015 | $422 |
| 2014 | $782 |
| 2013 | $898 |
| 2012 | $1,304 |
| 2011 | $1,190 |
| 2010 | $1,092 |
| 2009 | $884 |
| Cencora Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $706 |
| 2024-09-30 | $127 |
| 2024-06-30 | $672 |
| 2024-03-31 | $553 |
| 2023-12-31 | $823 |
| 2023-09-30 | $477 |
| 2023-06-30 | $670 |
| 2023-03-31 | $561 |
| 2022-12-31 | $633 |
| 2022-09-30 | $455 |
| 2022-06-30 | $487 |
| 2022-03-31 | $780 |
| 2021-12-31 | $644 |
| 2021-09-30 | $562 |
| 2021-06-30 | $621 |
| 2021-03-31 | $624 |
| 2020-12-31 | $547 |
| 2020-09-30 | $-6,113 |
| 2020-06-30 | $405 |
| 2020-03-31 | $310 |
| 2019-12-31 | $263 |
| 2019-09-30 | $180 |
| 2019-06-30 | $407 |
| 2019-03-31 | $48 |
| 2018-12-31 | $478 |
| 2018-09-30 | $154 |
| 2018-06-30 | $389 |
| 2018-03-31 | $481 |
| 2017-12-31 | $419 |
| 2017-09-30 | $-135 |
| 2017-06-30 | $170 |
| 2017-03-31 | $625 |
| 2016-12-31 | $400 |
| 2016-09-30 | $225 |
| 2016-06-30 | $529 |
| 2016-03-31 | $950 |
| 2015-12-31 | $-178 |
| 2015-09-30 | $542 |
| 2015-06-30 | $333 |
| 2015-03-31 | $-364 |
| 2014-12-31 | $-88 |
| 2014-09-30 | $210 |
| 2014-06-30 | $111 |
| 2014-03-31 | $301 |
| 2013-12-31 | $160 |
| 2013-09-30 | $114 |
| 2013-06-30 | $135 |
| 2013-03-31 | $350 |
| 2012-12-31 | $299 |
| 2012-09-30 | $321 |
| 2012-06-30 | $324 |
| 2012-03-31 | $377 |
| 2011-12-31 | $281 |
| 2011-09-30 | $230 |
| 2011-06-30 | $317 |
| 2011-03-31 | $365 |
| 2010-12-31 | $277 |
| 2010-09-30 | $236 |
| 2010-06-30 | $282 |
| 2010-03-31 | $311 |
| 2009-12-31 | $262 |
| 2009-09-30 | $225 |
| 2009-06-30 | $213 |
| 2009-03-31 | $248 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $56.251B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.350B | 26.32 |
| Elevance Health (ELV) | United States | $91.117B | 11.76 |
| CVS Health (CVS) | United States | $79.102B | 9.83 |
| DiDi Global (DIDIY) | China | $21.979B | 33.36 |
| Natera (NTRA) | United States | $20.836B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.822B | 13.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.604B | 0.00 |
| CochLear (CHEOY) | Australia | $11.282B | 0.00 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| ICON (ICLR) | Ireland | $10.630B | 9.88 |
| Viatris (VTRS) | United States | $10.375B | 3.56 |
| Doximity (DOCS) | United States | $9.813B | 45.70 |
| Avantor (AVTR) | United States | $9.138B | 13.28 |
| Medpace Holdings (MEDP) | United States | $8.785B | 23.33 |
| HealthEquity (HQY) | United States | $8.497B | 41.80 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.924B | 13.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.257B | 39.40 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| Sotera Health (SHC) | United States | $3.633B | 20.65 |
| Alignment Healthcare (ALHC) | United States | $3.122B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.068B | 39.90 |
| Concentras Parent (CON) | United States | $2.912B | 16.83 |
| Organon (OGN) | United States | $2.350B | 2.50 |
| Ardent Health Partners (ARDT) | United States | $2.204B | 9.40 |
| GeneDx Holdings (WGS) | United States | $1.949B | 75.07 |
| Progyny (PGNY) | United States | $1.912B | 42.08 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| PACS (PACS) | United States | $1.647B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.414B | 28.29 |
| Teladoc Health (TDOC) | United States | $1.319B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.283B | 9.76 |
| Establishment Labs Holdings (ESTA) | $1.046B | 0.00 | |
| Agilon Health (AGL) | United States | $1.014B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 15.25 |
| Nutex Health (NUTX) | United States | $0.972B | 14.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.869B | 8.13 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.702B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.33 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.487B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.370B | 0.00 |
| SBC Medicals (SBC) | United States | $0.352B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.150B | 24.50 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| KindlyMD (KDLY) | United States | $0.078B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |